Brenda McKenzie, a high-ranking economic development official in Boston, is expected to be named on Monday as the next president…
Super UserNovember 18, 2012
What happens when the FDA approval process slows down and imposes higher hurdles, when cost-reduction becomes central to the healthcare…
Super UserNovember 14, 2012
Commemorating a year that positioned Maryland as a national leader in the innovation economy, DBED has released its FY 2012…
Super UserNovember 14, 2012
Maryland is the nation’s second best educated state with 36.9 percent of its population aged 25 or over holding a…
Super UserNovember 14, 2012
As part of today’s Maryland Entrepreneur Expo 2012 hosted by TEDCO, Maryland Department of Business and Economic Development (DBED) Secretary…
Super UserNovember 14, 2012
On November 8, 2012, the BioPark hosted Rachel King, CEO of GlycoMimetics, as part of its Business of Bio speaker…
Super UserNovember 14, 2012
Not that long ago, biotech executives weren’t sure who to call on Wall Street, or whether anyone would answer the…
Super UserNovember 12, 2012
GlaxoSmithKline, the new owner of Rockville's Human Genome Sciences, cleared a significant regulatory hurdle last week when a Food and…
Super UserNovember 9, 2012
MedImmune, the global biologics arm of AstraZeneca PLC operating through various affiliates in the AstraZeneca Group, has approximately 5,500 full-time…
Super UserNovember 9, 2012